An interventional study of Midline traction oral appliance in Snoring and Sleep Fragmentation, sponsored by Texas A&M University. Recruiting at 1 site in United States. Open to female participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-10-07.
Sponsored by Texas A&M University · Not applicable, Interventional, and Treatment
Many pregnant women suffer from poor sleep quality and snoring. Evidence shows an increasing association between (1) sleep disordered breathing and (2) maternal cardiovascular disease and in-hospital death. Snoring is a variant of obstructive sleep apnea (OSA) and OSA during pregnancy is associated with higher risks for cesarean delivery, gestational hypertension, preeclampsia and preterm delivery. It may also impact fetal outcomes negatively. The purpose of this study is to determine whether sleep quality can be improved in pregnant women who snore by means of an oral appliance that opens the airway. Sleep quality is evaluated objectively using an un-intrusive home sleep test system.
As many as 20 percent of women suffer from snoring and poor sleep quality while pregnant. The purpose of this study is to determine whether sleep can be improved in pregnant women who snore by means of a midline traction oral appliance (OA) that opens the airway. This is an interventional study to objectively evaluate OA therapy on breathing during sleep as well as its effect on sleep quality. Pregnant women from all trimesters will be recruited. Each subject is expected to participate in the study for at least five (5) consecutive weeks. Home sleep recordings will be collected at three time points: T0 - Baseline prior to OA use for two consecutive nights; T1- first two consecutive nights wearing the OA; T2 - for two consecutive nights after 4 weeks of appliance use. In addition to the sleep studies performed at each of these time points, subjects will also complete several brief surveys. All participants will be given the opportunity to use their OAs after the 4 week period, and have their sleep recorded at 8 week intervals through the remainder of their pregnancies. Participants will get to keep and use their OAs after the study.
Pregnant women who snore (or otherwise have poor sleep), may qualify to participate in this study. Those who do not want to wear an oral appliance, but are interested in learning about sleep quality while pregnant, may also qualify to participate as a control subject.
Exclusion Criteria:
Subjects will wear the oral appliance nightly for 4 weeks. Must snore or have other evidence of sleep disordered breathing.
Device: Midline traction oral appliance
Subjects who do do not wish to wear the oral appliance will have their sleep monitored in parallel to the experimental subjects for 4 weeks.
Device positions the mandible forward to open airway; device can be titrated to gradually advance the mandible.
Also known as: MyTAP oral appliance, Mandibular advancement device
Ratio of stable to unstable sleep from CPC
Ratio of stable to unstable sleep based on cardiopulmonary coupling analysis.
Time frame: Two nights of sleep recordings at each of 3 time point over 5 weeks.
Number of snores per hour of sleep
Number of snores and snore index (#snores/hour of sleep)
Time frame: At each of 3 time points over 5 weeks
Pittsburgh Sleep Quality Index (PSQI)
Self reported measures concerning sleep over a 1-month period; overall score ranging from 0 to 21; Scores \>7 suggests poor sleep quality.
Time frame: At baseline and after 5 weeks
Insomnia Sleep Questionnaire (ISQ)
A screening tool used to guide in the clinical evaluation of insomnia; Scores 3, 4 or 5 to two or more items suggests significant daytime impairment and further evaluation of insomnia.
Time frame: At baseline and after 5 weeks
Hamilton Depression Rating Scale (HDRS)
Used to provide an indication of depression, and as a guide to evaluate recovery; Higher scores = depression severity. Score \>20 suggests depression severity.
Time frame: At baseline and after 5 weeks
Fatigue Severity Scale (FSS)
9-item scale which measures the severity of fatigue and its effect on a person's activities; and lifestyle. Higher scores = greater fatigue severity. Minimum score = 9; Maximum score = 63.
Time frame: At baseline and after 5 weeks
Plan to share: No
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Texas A&M University